Àå¹ÙÀÌ·¯½º ¼ö¸·¿° ȯÀÚ¿¡¼­ ³úô¼ö¾× ¹éÇ÷±¸Áõ°¡Áõ À¯¹«¿¡ µû¸¥ ÀÓ»ó¾ç»óÀÇ ºñ±³
Clinical Comparison among Patients with Enteroviral Meningitis According to the Presence of CSF Pleocytosis

´ëÇѼҾƽŰæÇÐȸÁö 2014³â 22±Ç 2È£ p.58 ~ p.62

ÇãÅÂÈÆ(Heo Tea-Hoon) - °í·Á´ëÇб³ Àǰú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
±è°ÇÇÏ(Kim Gun-Ha) - °í·Á´ëÇб³ Àǰú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
º¯Á¤Çý(Byeon Jung-Hye) - °í·Á´ëÇб³ Àǰú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
Àº¹é¸°(Eun Baik-Lin) - °í·Á´ëÇб³ Àǰú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç

Abstract

¸ñÀû: Àå¹ÙÀÌ·¯½º ³ú¼ö¸·¿°¿¡¼­ RT-PCRÀ» ÅëÇØ Àå¹ÙÀÌ·¯½º°¡ °ËÃâµÇ¾úÁö¸¸ ³úô¼ö¾×¿¡¼­ ¹éÇ÷±¸Áõ°¡Áõ(pleocytosis)ÀÌ º¸ÀÌÁö ¾Ê´Â Áõ·ÊµéÀÌ Á¾Á¾ Àִµ¥ ¹éÇ÷±¸Áõ°¡ÁõÀ» º¸ÀÌ´Â °æ¿ì¿Í º¸ÀÌÁö ¾Ê´Â °æ¿ì¿¡ ÀÓ»óÀûÀÎ Â÷ÀÌÁ¡¿¡ ´ëÇÑ ¿¬±¸µéÀº ºÎÁ·ÇÑ ½ÇÁ¤ÀÌ´Ù. ÀÌ¿¡ ÀúÀÚµéÀº ¼Ò¾Æ ¹«±Õ¼º Àå¹ÙÀÌ·¯½º ³ú¸·¿°À¸·Î Áø´Ü¹Þ¾Ò´ø ȯÀÚµéÀ» ´ë»óÀ¸·Î ¹éÇ÷±¸Áõ°¡ÁõÀÌ ÀÖ¾ú´ø ȯÀÚ¿Í ¹éÇ÷±¸Áõ°¡ÁõÀÌ ¾ø¾ú´ø ȯ¾Æ·Î ºÐ·ùÇÏ¿© Áõ»ó ¹× °Ë»ç ¼Ò°ß µîÀÇ ÀÓ»óÀû Â÷ÀÌ¿¡ ´ëÇØ ¾Ë¾Æº¸°íÀÚ ÇÏ¿´´Ù.

¹æ¹ý: 2013³â 3¿ùºÎÅÍ 8¿ù±îÁö °í·Á´ëÇб³ ¾È»êº´¿ø°ú ±¸·Îº´¿ø¿¡¼­ ³ú¼ö¸·¿° ¹× ³ú¿°ÀÌ ÀÇ½ÉµÇ¾î ³úô¼ö¾× °Ë»ç¸¦ ¹ÞÀº 16¼¼ ¹Ì¸¸ ȯÀÚ Áß Àå¹ÙÀÌ·¯½º °¨¿°À¸·Î È®ÁøµÈ 49¸íÀÇ È¯ÀÚ¸¦ ³úô¼ö¾×¿¡¼­ ¹éÇ÷±¸Áõ°¡ÁõÀ» º¸ÀÎ ±×·ì°ú ¹éÇ÷±¸Áõ°¡ÁõÀ» º¸ÀÌÁö ¾ÊÀº ±×·ìÀ¸·Î ³ª´©¾î ÀÓ»óÀûÀÎ Â÷ÀÌ À¯¹«¸¦ ºñ±³ÇÏ¿´´Ù. ³ªÀÌ, ¹ß¿­±â°£, ÀÔ¿øÀϼö, Ç×»ýÁ¦ »ç¿ë±â°£, °æºÎ°­Á÷ À¯¹«, µÎÅë À¯¹«, ±¸Åä À¯¹« µîÀÇ ÀÓ»ó ¾ç»ó°ú ¸»ÃÊÇ÷¾× ¹éÇ÷±¸ ¼ö, Àý´ë È£Áß±¸ ¼ö, ³úô¼ö¾× ´Ü¹éÁú·®, ³úô¼ö¾×°ú Ç÷û ´ç ºñÀ² µîÀÇ °Ë»ç ¼Ò°ßÀ» ºÐ¼®º¯¼ö·Î ÇÏ¿´´Ù.

°á°ú: Àå¹ÙÀÌ·¯½º ¼ö¸·¿°À¸·Î Áø´ÜµÈ 49¸íÀÇ È¯¾Æ Áß 8¸í(16.3%)¿¡¼­ ³úô¼ö¾× ¹éÇ÷±¸Áõ°¡ÁõÀÌ µ¿¹ÝµÇÁö ¾Ê¾Ò´Ù. ³úô¼ö¾× ¹éÇ÷±¸Áõ°¡ÁõÀÌ ÀÖ´Â ±º°ú ¾ø´Â ±º °£ÀÇ ÀÓ»óÁõ»óÀÇ ÀÇ¹Ì ÀÖ´Â Â÷ÀÌ´Â ¾ø¾úÀ¸¸ç ¸»ÃÊÇ÷¾× °Ë»ç ¹× ³úô¼ö¾× ¹éÇ÷±¸ ¼ö, ³úô¼ö¾×/Ç÷û ´ç ºñÀ²¿¡ À־µµ Åë°èÀû À¯ÀǼºÀ» º¸ÀÌÁö ¾Ê¾Ò´Ù(Table 3). ±×·¯³ª ³úô¼ö¾× ´Ü¹éÁú ³óµµÀÇ °æ¿ì ³úô¼ö¾× ¹éÇ÷±¸Áõ°¡ÁõÀÌ ¾ø¾ú´ø ±×·ìÀº Æò±Õ 18.9¡¾4.3 mg/dL·Î ¹éÇ÷±¸Áõ°¡ÁõÀ» º¸¿´´ø ±×·ì(34.9¡¾18.3 mg/dL)¿¡ ºñÇØ À¯ÀÇÇÏ°Ô ³·¾Ò´Ù(P=0.002).

°á·Ð: Àå¹ÙÀÌ·¯½º ¼ö¸·¿°¿¡¼­ ³úô¼ö¾× ¹éÇ÷±¸Áõ°¡ÁõÀÌ µ¿¹ÝµÇÁö ¾Ê´Â °æ¿ì°¡ ÀÖÀ¸¹Ç·Î ÀÓ»óÀûÀ¸·Î ÀǽÉÀÌ µÇ´Â °æ¿ì¿¡´Â PCRÀ» ½ÃÇàÇÏ´Â °ÍÀÌ ÃßõµÈ´Ù. ±×¸®°í ÀÌ´Â Á¤È®ÇÑ Áø´Ü°ú ´õºÒ¾î ºÒÇÊ¿äÇÑ ÀÔ¿ø±â°£À̳ª Ç×»ýÁ¦ »ç¿ëÀ» ÁÙÀÌ´Â µ¥ µµ¿òÀÌ µÉ °ÍÀ¸·Î »ý°¢µÈ´Ù.
Purpose: The aim of this study was to evaluate the difference of clinical features among patients with enteroviral mengitis according to the presence of cerebrospinal fluid (CSF) pleocytosis.

Methods: This was a retrospective analysis of the patients¡¯ data diagnosed with enteroviral meningitis by CSF reverse transcriptase polymerase chain reaction (RT-PCR). We reviewed the medical records of children younger than 16 years who visited Korea University Ansan Hospital and Guro Hospital for meningitis or encephalitis between March 2013 and August 2013. Clinical and laboratory variables were compared with regard to the presence of CSF pleocytosis.

Results: Among 49 patients with enteroviral meningitis, eight of 49 (16.3%) did not have pleocytosis. The enteroviral meningitis patients without pleocytosis had lower CSF protein level than patients with pleocytosis (18.9¡¾4.3 vs 34.9¡¾18.3 mg/ dL; P=0.002). Age, duration of hospital stay, severity of clinical symptom, peripheral white cell blood counts, absolute neutrophil counts and CSF/serum glucose ratio were not different between two groups.

Conclusion: Enteroviral meningitis could manifest without pleocytosis. We therefore think that CSF RT-PCR is helpful for the diagnosis, especially in suspected cases, which leads to shorter hospital stay and minimal use of antibiotics.

Ű¿öµå

Enterovirus, Pleocytosis, Meningitis, Child
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Ű¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆÇ³âµµ(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå